Frank Koentgen

Dr Frank Koentgen is a successful entrepreneur, scientist, and international biotechnology leader with more than 25 years of experience in research and development in molecular genetics. He received his PhD from the University of Freiburg, Germany in affiliation with the Max Planck Institute (MPI) for Immunobiology and Roche Pharmaceuticals (Basel, Switzerland). His work there culminated in the establishment of the world’s first successful C57BL/6 knockout mouse. Dr Koentgen then went on to complete postdoctoral research at the Roche Institute for Molecular Biology (RIMB) located in Nutley, New Jersey, USA. After completing his initial postdoctoral research, he was awarded a German DFG research fellowship and moved to the Walter and Eliza Hall Institute (WEHI) in Melbourne. His research at the WEHI resulted in numerous peer-reviewed publications in prestigious scientific journals and multiple patents granted worldwide.